Premium
Monte Rosa Therapeutics Inc (GLUE)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Actionnaire | Type | Détenues (Réel) | % en Circulation | Valeur Marchande | Date de Reporte |
|---|---|---|---|---|---|
| New Enterprise Associates, Inc. | Institution | 7 692 298 | 9,11% | US$ 186,23M | 2026-03-31 |
| New Enterprise Associates 17, L.P. | Institution | 7 692 298 | 9,11% | US$ 186,23M | 2026-03-17 |
| T. Rowe Price Group, Inc. | Institution | 6 720 188 | 7,95% | US$ 162,70M | 2026-03-31 |
| BlackRock, Inc. | Institution | 5 637 684 | 6,67% | US$ 136,49M | 2026-03-31 |
| TCG Crossover Management, LLC | Institution | 4 622 151 | 5,47% | US$ 111,90M | 2026-03-31 |
| BVF Partners L.P. | Institution | 4 460 886 | 5,28% | US$ 108,00M | 2026-03-31 |
| Baker Bros. Advisors LP | Institution | 4 345 736 | 5,14% | US$ 105,21M | 2026-03-31 |
| Suvretta Capital Management, LLC | Institution | 4 226 809 | 5,00% | US$ 102,33M | 2026-03-31 |
| Vestal Point Capital, LP | Institution | 3 603 465 | 4,27% | US$ 87,24M | 2026-03-31 |
| State Street Global Advisors, Inc. | Institution | 3 353 980 | 3,97% | US$ 81,20M | 2026-03-31 |
| Braidwell LP | Institution | 3 206 574 | 3,80% | US$ 77,63M | 2026-03-31 |
| Versant Venture Management, LLC | Institution | 3 180 780 | 3,77% | US$ 77,01M | 2026-03-31 |
| Averill Master Fund, Ltd. | Institution | 3 147 448 | 3,73% | US$ 76,20M | 2025-04-09 |
| Vanguard Capital Management, LLC | Institution | 3 100 245 | 3,67% | US$ 75,06M | 2026-03-31 |
| American Century Investment Management Inc | Institution | 2 809 647 | 3,33% | US$ 68,02M | 2026-03-31 |
| Biotechnology Value Fund L.P. | Institution | 2 382 732 | 2,82% | US$ 57,69M | 2026-03-31 |
| Versant Venture Capital VI | Institution | 2 236 708 | 2,65% | US$ 54,15M | 2026-01-08 |
| TCG Crossover Fund II, L.P. | Institution | 2 213 853 | 2,62% | US$ 53,60M | 2025-10-10 |
| Silverarc Capital Management, LLC | Institution | 2 002 040 | 2,37% | US$ 48,47M | 2026-03-31 |
| Biotechnology Value Fund II, L.P. | Institution | 1 742 806 | 2,06% | US$ 42,19M | 2026-03-31 |
| Aisling Capital Management LP | Institution | 1 555 664 | 1,84% | US$ 37,66M | 2026-03-31 |
| Geode Capital Management, LLC | Institution | 1 540 812 | 1,82% | US$ 37,30M | 2026-03-31 |
| Marshall Wace LLP | Institution | 1 433 152 | 1,70% | US$ 34,70M | 2026-03-31 |
| Bellevue Asset Management AG | Institution | 1 250 000 | 1,48% | US$ 30,26M | 2026-03-31 |
| MPM BioImpact LLC | Institution | 1 176 928 | 1,39% | US$ 28,49M | 2026-03-31 |
| Dimensional Fund Advisors LP | Institution | 1 041 372 | 1,23% | US$ 25,21M | 2026-03-31 |
| FMR LLC | Institution | 1 024 304 | 1,21% | US$ 24,80M | 2026-03-31 |
| Versant Vantage I, L.P. | Institution | 1 013 361 | 1,20% | US$ 24,53M | 2026-01-08 |
| Frazier Life Sciences Management, LP | Institution | 1 000 000 | 1,18% | US$ 24,21M | 2026-03-31 |
| The Goldman Sachs Group, Inc. | Institution | 891 158 | 1,05% | US$ 21,57M | 2026-03-31 |
| Bridgeway Capital Management, LLC | Institution | 834 096 | 0,99% | US$ 20,19M | 2026-03-31 |
| Northern Trust Global Investments | Institution | 826 624 | 0,98% | US$ 20,01M | 2026-03-31 |
| Janus Henderson Group plc | Institution | 685 926 | 0,81% | US$ 16,61M | 2026-03-31 |
| GV Management Company, LLC | Institution | 684 275 | 0,81% | US$ 16,57M | 2026-03-31 |
| Nantahala Capital Management, LLC | Institution | 651 993 | 0,77% | US$ 15,78M | 2026-03-31 |
| Arrowstreet Capital, Limited Partnership | Institution | 647 739 | 0,77% | US$ 15,68M | 2026-03-31 |
| First Trust Advisors LP | Institution | 647 446 | 0,77% | US$ 15,67M | 2026-06-30 |
| AQR Capital Management, LLC | Institution | 621 697 | 0,74% | US$ 15,05M | 2026-03-31 |
| Morgan Stanley | Institution | 582 969 | 0,69% | US$ 14,11M | 2026-03-31 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
